KEGG   PATHWAY: csab05032
Entry
csab05032                   Pathway                                
Name
Morphine addiction - Chlorocebus sabaeus (green monkey)
Description
Morphine is an alkaloid from the plant extracts of opium poppy. Although morphine is highly effective for the treatment of pain, it is also known to be intensely addictive. We now know that the most important brain-reward circuit involves dopamine (DA) -containing neurons in the ventral tegmental area (VTA) of the midbrain and their target areas in the limbic forebrain, in particular, the nucleus accumbens (NAc) and frontal regions of cerebral cortex. Morphine can cause indirect excitation of VTA dopamine neurons by reducing inhibitory synaptic transmission mediated by GABAergic neurons. The chronic use of morphine is characterized by adaptive changes in neurons and neuronal communication; such adaptations (e.g., 'superactivation' of adenylyl cyclase) must underlie altered behaviour associated with morphine dependence and withdrawal syndrome, as well as drug-induced craving and relapse to drug use.
Class
Human Diseases; Substance dependence
Pathway map
csab05032  Morphine addiction
csab05032

Other DBs
GO: 0043278
Organism
Chlorocebus sabaeus (green monkey) [GN:csab]
Gene
103240750  OPRM1; opioid receptor mu 1 [KO:K04215]
103245015  DRD1; dopamine receptor D1 [KO:K04144]
103226115  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]
103214981  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]
103220665  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
103228726  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
103228169  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
103238242  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]
103232667  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
103237447  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]
103227576  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
103246166  SLC32A1; solute carrier family 32 member 1 [KO:K15015]
103217112  KCNJ3; potassium voltage-gated channel subfamily J member 3 [KO:K04997]
103218752  KCNJ6; potassium voltage-gated channel subfamily J member 6 [KO:K05000]
103223740  KCNJ9; potassium voltage-gated channel subfamily J member 9 [KO:K05002]
103248811  KCNJ5; potassium voltage-gated channel subfamily J member 5 [KO:K04999]
103234371  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]
103239541  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]
103232759  GABRA3; gamma-aminobutyric acid type A receptor alpha3 subunit [KO:K05175]
103244913  GABRA1; gamma-aminobutyric acid type A receptor alpha1 subunit [KO:K05175]
103244915  GABRA6; gamma-aminobutyric acid type A receptor alpha6 subunit [KO:K05175]
103246006  GABRA5; gamma-aminobutyric acid type A receptor alpha5 subunit [KO:K05175]
103246143  GABRA4; gamma-aminobutyric acid type A receptor alpha4 subunit [KO:K05175]
103246148  GABRA2; gamma-aminobutyric acid type A receptor alpha2 subunit [KO:K05175]
103246008  GABRB3; gamma-aminobutyric acid type A receptor beta3 subunit [KO:K05181]
103244912  GABRB2; gamma-aminobutyric acid type A receptor beta2 subunit [KO:K05181]
103246145  GABRB1; gamma-aminobutyric acid type A receptor beta1 subunit [KO:K05181]
103244917  GABRG2; gamma-aminobutyric acid type A receptor gamma2 subunit [KO:K05186]
103246004  GABRG3; gamma-aminobutyric acid type A receptor gamma3 subunit [KO:K05186]
103246149  GABRG1; gamma-aminobutyric acid type A receptor gamma1 subunit [KO:K05186]
103225775  GABRD; gamma-aminobutyric acid type A receptor delta subunit [KO:K05184]
103232754  GABRE; gamma-aminobutyric acid type A receptor epsilon subunit [KO:K05185]
103232761  GABRQ; gamma-aminobutyric acid type A receptor theta subunit [KO:K05192]
103244961  GABRP; gamma-aminobutyric acid type A receptor pi subunit [KO:K05189]
103228486  GABRR3; gamma-aminobutyric acid type A receptor rho3 subunit [KO:K05190]
103240098  GABRR1; gamma-aminobutyric acid type A receptor rho1 subunit [KO:K05190]
103240100  GABRR2; gamma-aminobutyric acid type A receptor rho2 subunit [KO:K05190]
103219146  GABBR2; gamma-aminobutyric acid type B receptor subunit 2 [KO:K04615]
103221881  GABBR1; gamma-aminobutyric acid type B receptor subunit 1 [KO:K04615]
103227664  GNAI2; G protein subunit alpha i2 [KO:K04630]
103224284  GNAI3; G protein subunit alpha i3 [KO:K04630]
103226652  GNAI1; G protein subunit alpha i1 [KO:K04630]
103233012  GNAO1; G protein subunit alpha o1 [KO:K04534]
103225777  GNB1; G protein subunit beta 1 [KO:K04536]
103246723  GNB2; G protein subunit beta 2 [KO:K04537]
103218476  GNB3; G protein subunit beta 3 [KO:K07825]
103221209  GNB4; G protein subunit beta 4 [KO:K04538]
103245611  GNB5; G protein subunit beta 5 [KO:K04539]
103228983  GNG2; G protein subunit gamma 2 [KO:K07826]
103233940  GNG3; G protein subunit gamma 3 [KO:K04540]
103236336  GNG5; G protein subunit gamma 5 [KO:K04542]
103233652  GNG7; G protein subunit gamma 7 [KO:K04543]
103234920  GNG8; G protein subunit gamma 8 [KO:K04544]
103219014  GNG10; G protein subunit gamma 10 [KO:K04545]
103226542  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
103224649  GNG12; G protein subunit gamma 12 [KO:K04347]
103243636  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]
103243509  GNAS; GNAS complex locus [KO:K04632]
103243499  neuroendocrine secretory protein 55 [KO:K04632]
103219132  GRK2; G protein-coupled receptor kinase 2 [KO:K00910] [EC:2.7.11.15]
103223079  GRK3; G protein-coupled receptor kinase 3 [KO:K00910] [EC:2.7.11.15]
103246447  GRK4; G protein-coupled receptor kinase 4 [KO:K08291] [EC:2.7.11.16]
103245054  GRK6; G protein-coupled receptor kinase 6 [KO:K08291] [EC:2.7.11.16]
103216606  GRK5; G protein-coupled receptor kinase 5 [KO:K08291] [EC:2.7.11.16]
103248056  ARRB1; arrestin beta 1 [KO:K04439]
103242194  ARRB2; arrestin beta 2 [KO:K04439]
103243171  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
103229829  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
103235232  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
103219549  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
103224540  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
103234377  cAMP-dependent protein kinase catalytic subunit alpha-like [KO:K04345] [EC:2.7.11.11]
103226260  PDE1C; phosphodiesterase 1C [KO:K13755] [EC:3.1.4.17]
103238444  PDE1B; phosphodiesterase 1B [KO:K13755] [EC:3.1.4.17]
103217462  PDE1A; phosphodiesterase 1A [KO:K13755] [EC:3.1.4.17]
103248002  PDE2A; phosphodiesterase 2A [KO:K18283] [EC:3.1.4.17]
103218726  PDE3A; phosphodiesterase 3A [KO:K19021] [EC:3.1.4.17]
103239798  PDE3B; phosphodiesterase 3B [KO:K13296] [EC:3.1.4.17]
103221883  PDE4D; phosphodiesterase 4D [KO:K13293] [EC:3.1.4.53]
103234171  PDE4C; phosphodiesterase 4C [KO:K13293] [EC:3.1.4.53]
103234361  cAMP-specific 3',5'-cyclic phosphodiesterase 4A-like [KO:K13293] [EC:3.1.4.53]
103224666  PDE4B; phosphodiesterase 4B [KO:K13293] [EC:3.1.4.53]
103236892  PDE7A; phosphodiesterase 7A [KO:K18436] [EC:3.1.4.53]
103240324  PDE7B; phosphodiesterase 7B [KO:K18436] [EC:3.1.4.53]
103223403  PDE8B; phosphodiesterase 8B [KO:K18437] [EC:3.1.4.53]
103231102  PDE8A; phosphodiesterase 8A [KO:K18437] [EC:3.1.4.53]
103240896  PDE10A; phosphodiesterase 10A [KO:K18438] [EC:3.1.4.17 3.1.4.35]
103217403  PDE11A; phosphodiesterase 11A [KO:K13298] [EC:3.1.4.17 3.1.4.35]
103230289  ADORA1; adenosine A1 receptor [KO:K04265]
Compound
C00020  AMP
C00076  Calcium cation
C00212  Adenosine
C00238  Potassium cation
C00334  4-Aminobutanoate
C00575  3',5'-Cyclic AMP
C00698  Cl-
C03758  Dopamine
D00842  Morphine sulfate (USP)
D02271  Morphine hydrochloride hydrate (JP18)
D08233  Morphine (BAN)
D08234  Morphine tartrate
Reference
PMID:15661627
  Authors
Bailey CP, Connor M
  Title
Opioids: cellular mechanisms of tolerance and physical dependence.
  Journal
Curr Opin Pharmacol 5:60-8 (2005)
DOI:10.1016/j.coph.2004.08.012
Reference
PMID:11152760
  Authors
Williams JT, Christie MJ, Manzoni O
  Title
Cellular and synaptic adaptations mediating opioid dependence.
  Journal
Physiol Rev 81:299-343 (2001)
DOI:10.1152/physrev.2001.81.1.299
Reference
PMID:16581089
  Authors
Gintzler AR, Chakrabarti S
  Title
Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules.
  Journal
Life Sci 79:717-22 (2006)
DOI:10.1016/j.lfs.2006.02.016
Reference
PMID:8785060
  Authors
Bonci A, Williams JT
  Title
A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine.
  Journal
Neuron 16:631-9 (1996)
DOI:10.1016/S0896-6273(00)80082-3
Reference
PMID:11750924
  Authors
Liu JG, Anand KJ
  Title
Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence.
  Journal
Brain Res Brain Res Rev 38:1-19 (2001)
DOI:10.1016/S0165-0173(01)00057-1
Reference
PMID:10066284
  Authors
Shoji Y, Delfs J, Williams JT
  Title
Presynaptic inhibition of GABA(B)-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal.
  Journal
J Neurosci 19:2347-55 (1999)
DOI:10.1523/JNEUROSCI.19-06-02347.1999
Reference
PMID:18349442
  Authors
Zhang Y, Chen Q, Yu LC
  Title
Morphine: a protective or destructive role in neurons?
  Journal
Neuroscientist 14:561-70 (2008)
DOI:10.1177/1073858408314434
Reference
PMID:12859419
  Authors
Tso PH, Wong YH
  Title
Molecular basis of opioid dependence: role of signal regulation by G-proteins.
  Journal
Clin Exp Pharmacol Physiol 30:307-16 (2003)
DOI:10.1046/j.1440-1681.2003.03835.x
Reference
PMID:1346804
  Authors
Johnson SW, North RA
  Title
Opioids excite dopamine neurons by hyperpolarization of local interneurons.
  Journal
J Neurosci 12:483-8 (1992)
DOI:10.1523/JNEUROSCI.12-02-00483.1992
Reference
PMID:20962224
  Authors
Madhavan A, Bonci A, Whistler JL
  Title
Opioid-Induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area.
  Journal
J Neurosci 30:14029-35 (2010)
DOI:10.1523/JNEUROSCI.3366-10.2010
Reference
PMID:8987801
  Authors
Bonci A, Williams JT
  Title
Increased probability of GABA release during withdrawal from morphine.
  Journal
J Neurosci 17:796-803 (1997)
DOI:10.1523/JNEUROSCI.17-02-00796.1997
Reference
PMID:21872647
  Authors
Morikawa H, Paladini CA
  Title
Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms.
  Journal
Neuroscience 198:95-111 (2011)
DOI:10.1016/j.neuroscience.2011.08.023
Reference
PMID:12217944
  Authors
Xi ZX, Stein EA
  Title
GABAergic mechanisms of opiate reinforcement .
  Journal
Alcohol Alcohol 37:485-94 (2002)
DOI:10.1093/alcalc/37.5.485
Reference
PMID:8096779
  Authors
Kalivas PW
  Title
Neurotransmitter regulation of dopamine neurons in the ventral tegmental area.
  Journal
Brain Res Brain Res Rev 18:75-113 (1993)
DOI:10.1016/0165-0173(93)90008-N
Reference
PMID:21930931
  Authors
Jalabert M, Bourdy R, Courtin J, Veinante P, Manzoni OJ, Barrot M, Georges F
  Title
Neuronal circuits underlying acute morphine action on dopamine neurons.
  Journal
Proc Natl Acad Sci U S A 108:16446-50 (2011)
DOI:10.1073/pnas.1105418108
Reference
PMID:14625081
  Authors
Chakrabarti S, Gintzler AR
  Title
Phosphorylation of Gbeta is augmented by chronic morphine and enhances Gbetagamma stimulation of adenylyl cyclase activity.
  Journal
Brain Res Mol Brain Res 119:144-51 (2003)
DOI:10.1016/j.molbrainres.2003.09.002
Reference
PMID:14969742
  Authors
Ferrer-Alcon M, La Harpe R, Garcia-Sevilla JA
  Title
Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts.
  Journal
Brain Res Mol Brain Res 121:114-22 (2004)
DOI:10.1016/j.molbrainres.2003.11.009
Related
pathway
csab04727  GABAergic synapse
csab04728  Dopaminergic synapse
KO pathway
ko05032   
LinkDB

DBGET integrated database retrieval system